Stroke and Vascular Neurology

Article	Citations
Photochemically induced thalamus infarction impairs cognition in a mouse model	92
Long-term clinical outcome after extracranial–intracranial bypass surgery for atherosclerotic vessel occlusion in patients with diminished cerebrovascular reserve capacity and recurrent ischaemic even	91
CerebrAlcare Pills on CereBral Small VesseL DiseasE (CABLE) trial: rationale and design	71
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications	54
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry	52
Efficacy of immediate anti-hypertensive treatment in patients with acute ischaemic stroke stratified by mean arterial pressure and pulse pressure: a secondary analysis of the China Antihypertensive Tr	43
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model	32
Letter to the editor: risk factors for cervical artery dissection – a systematic review with meta-analysis	30
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial	30
30 years of thrombolysis for ischaemic stroke: expanded agents, widened windows and accelerated delivery	29
Contact aspiration versus stent retriever thrombectomy for acute basilar artery occlusion (ANGEL-COAST): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint tr	28
Multiomics genetic insights into potential molecular targets for intracranial aneurysm	25
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospe	25
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction	24
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP	24
Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial	23
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial	22
Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores	22
Association of socioeconomic status with intracranial arterial plaque: mediated by cardiometabolic risk factors	21
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway	21
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study	20
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation	20
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke	20
Endovascular treatment for basilar artery occlusion: a meta-analysis	20
LRRC8A in endothelial cells contributes to the aberrant blood-brain barrier integrity in ischaemic stroke	20

Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy	19
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort	19
Tongxinluo capsule in the treatment of cerebral small vessel disease: protocol of a randomised, double-blind, placebo-controlled, multicentre clinical study (TOPS-CSVD)	18
Adjunct tirofiban treatment after successful endovascular thrombectomy recanalisation in acute anterior circulation ischaemic stroke (ATTRACTION): protocol of a multicentre, prospective, double-blinde	18
Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack	18
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review	18
Arteriolosclerosis differs from venular collagenosis in relation to cerebrovascular parenchymal damages: an autopsy-based study	17
Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus	16
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study	16
CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats	16
Discontinuation of antiplatelet therapy after stent-assisted coil embolisation of cerebral aneurysm: a nationwide cohort study	16
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study	16
Angioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula	16
Head-down position after reperfusion improves cerebral ischaemic injury in rat	15
Framework for developing intracerebral haemorrhage recognition scales and technologies for hyperacute prehospital blood pressure lowering	15
Cerebrovascular cinematic rendering of multisystemic smooth muscle dysfunction syndrome	15
STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke	15
Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial	15
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study	15
Quantitative histopathological analysis of thrombi retrieved by mechanical thrombectomy and their association with stroke aetiology	15
Src inhibition rescues FUNDC1-mediated neuronal mitophagy in ischaemic stroke	15
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA	14
Thrombolytic agents, more options, more challenges	14
Extracellular vesicles bearing serum amyloid A1 exacerbate neuroinflammation after intracerebral haemorrhage	14
Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial	14
Rationale and design of Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined with Endovascular Treatment in ACute Ischaemic StrokE (RETRACE II): a randomised double-blind controlled mul	14
BEST-BAO: a multicentre, prospective, randomised controlled trial of endovascular treatment with or without intravenous thrombolysis in acute ischaemic stroke due to basilar artery occlusion – study p	13
Central post-stroke pain: advances in clinical and preclinical research	13
Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry	13
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury	13
Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale	13
Baseline systolic blood pressure and efficacy of dual antiplatelet in acute ischaemic stroke	13
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to impro	13
Sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections	13
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial	12
Clinical utility of measuring circulating glial fibrillary acidic protein in severe stroke	12
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study	12
Early blood pressure lowering and cerebral oedema in thrombolysis-treated stroke: secondary analysis of the ENCHANTED trial	11
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications	11
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study	11
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–2020	11
AI-Based STroke Risk fActor Classification and Treatment (ABSTRACT) study	11
Definitions of white matter hyperintensity change: impact on estimates of progression and regression	11
Outcomes of Onyx embolisation as primary treatment for intracranial dural arteriovenous fistulas over the past two decades	11
Brain-targeted extracellular vesicles for anti-cuproptosis therapy in subarachnoid haemorrhage	10
Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary results	10
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study	10
CSA declaration of next-generation reperfusion therapy for ischaemic stroke	10
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage	10
Secondary stroke evaluation in patients admitted for CRAO in a large national inpatient sample	10

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy	9
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects	9
COP27 climate change conference: urgent action needed for Africa and the world	9
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats	9
Effect of a regional guideline-education initiative on dual antiplatelet therapy use in minor non-cardioembolic stroke: a pre–post analysis from the Shanghai Stroke Service System	9
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry	9
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-	9
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry	9
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study	9
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial	9
Young stroke in Bangladesh: addressing rare cases with diagnostic challenges and much-needed solutions	9
Incidence and prevalence of vascular cognitive impairment in China: a systematic review and meta-analysis	9
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations	9
VasCog Screen test: sensitive in detecting cognitive impairment in patients who had a stroke or with heart failure	8
Real-world analysis of two ischaemic stroke and TIA systolic blood pressure goals on 12-month mortality and recurrent vascular events	8
Why non-human primates are needed in stroke preclinical research	8
Haemorrhage after thrombectomy with adjuvant thrombolysis in unknown onset stroke depends on high early lesion water uptake	8
Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study	8
Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2	8
Improving detection of cerebral small vessel disease aetiology in patients with isolated lobar intracerebral haemorrhage	8
Impaired glymphatic system as evidenced by low diffusivity along perivascular spaces is associated with cerebral small vessel disease: a population-based study	8
Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the umbrella phase IIa CHABLIS-T randomised clinical trial	8
Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneou	8
Predictors of futile recanalisation in patients with large infarct: a post-hoc analysis of the ANGEL-ASPECT trial	8
Differential associations of lipoprotein(a) level with cerebral large artery and small vessel diseases	8
Associations of accelerated biological ageing with incident dementia, cognitive functions and brain structure: a prospective cohort study based on UK Biobank	8
Neuronavigation-assisted stereotactic minimally invasive puncture with tenecteplase for the treatment of acute spontaneous deep intracerebral haemorrhage (NAS-TNK): rationale and design of a multicent	8
Safety and Efficacy of Remote Ischaemic Conditioning for Acute Ischaemic Stroke Treated with Mechanical Thrombectomy (RECAST-MT): rationale and design	7
Paediatric intracranial dural arteriovenous fistulas: clinical characteristics, treatment outcomes and prognosis	7
Chinese Stroke Association guidelines for clinical management of ischaemic cerebrovascular diseases: executive summary and 2023 update	7
Rationale and design of a PROBE trial comparing continuous enteral nutrition to time-restricted enteral nutrition in severe stroke	6
PRCP is a promising drug target for intracranial aneurysm rupture supported via multi-omics analysis	6
Clinical features, treatment and long-term outcomes of hemorrhagic moyamoya disease in children: an extensive follow-up study	6
Frequent flyers: recurrent large vessel occlusion requiring thrombectomy	6
Multicentre prospective, randomised open-label, endpoint-blinded study to evaluate the safety and efficacy of propranolol for the prevention of stroke-associated pneumonia in patients with intracerebr	6
New rat model of spinal cord infarction with long-lasting functional disabilities generated by intraspinal injection of endothelin-1	6
Isolated anterior cerebral artery occlusion: an atypical form of moyamoya disease	6
Model based on single-nucleotide polymorphism to discriminate aspirin resistance patients	6
Application of bedside HINTS, ABCD2 score and truncal ataxia to differentiate cerebellar–brainstem stroke from vestibular neuritis in the emergency room	6
Long-term outcome in a cohort of 36 patients with sacral dural arteriovenous fistulae after endovascular embolisation or microsurgery	6
Dual versus mono antiplatelet therapy within 72 hours after onset for mild ischaemic stroke or transient ischaemic attack: meta-analysis of randomised controlled trials	6
Machine learning models for predicting futile recanalisation after endovascular treatment in patients with large core infarction	6
Correlation of enlarged perivascular spaces in basal ganglion and cancer-associated stroke: a case–control study in China	6
Is intraprocedural intravenous aspirin safe for patients who require emergent extracranial stenting during mechanical thrombectomy?	6
Association between Life’s Essential 8 and Cerebral Small Vessel Disease	6
Clinical outcomes of endovascular interventions for cerebral venous thrombosis in Japan: a nationwide retrospective study	6
Intra-arterial tenecteplase during thrombectomy for acute stroke (BRETIS-TNK II): rationale and design	6
Bone marrow-derived mesenchymal stem cell ameliorates post-stroke enterobacterial translocation through liver-gut axis	5
CHinese Acute Tissue-Based Imaging Selection for Lysis In Stroke Tenecteplase II (CHABLIS-T II): rationale and design	5
Asymptomatic carotid artery stenosis is associated with increased Alzheimer’s disease and non-Alzheimer’s disease dementia risk	5
Endovascular treatment for symptomatic intracranial artery stenosis: current strategies and future challenges	5
Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial	5
Protective effects of melatonin on stroke in diabetic mice: central and peripheral inflammation modulation	5
Time to treat the climate and nature crisis as one indivisible global health emergency	5
In patients who had a stroke or TIA, enlarged perivascular spaces in basal ganglia may cause future haemorrhagic strokes	5
Stroke medicine: what’s next?	5
Efficacy of Papaverine to Prevent Radial Artery Spasm During Transradial Cerebral Angiography (PASS): rationale and design	5
Chinese Stroke Association guidelines on emergency stroke unit	5
Distribution and prognosis of acute ischaemic stroke with negative diffusion-weighted imaging	5
Intracerebral haemorrhage laterality and associations with mood and pain: a MISTIE III substudy	5
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018	5
Comparing the effectiveness and safety of rescue balloon angioplasty versus stenting in acute large vessel occlusion after thrombectomy	5
Roles of light transmission aggregometry and CYP2C19 genotype in predicting ischaemic complications during interventional therapy for intracranial aneurysms	5
Should patients with minor strokes be given thrombolytics?	5
Rationale and design of Treatment of Acute Ischaemic Stroke with Edaravone Dexborneol II (TASTE-2): a multicentre randomised controlled trial	5
Association of fluid balance with 3-month outcomes in severe acute ischaemic stroke	4
Pictures of stroke and cerebral vasculature: novel insights and detailed visualisation of U-shaped elastin distribution and disorganised fibre arrangement at carotid bifurcations by advanced technique	4
Comparing a novel Catfish flow restoration device and the Solitaire stent retriever for thrombectomy revascularisation in emergent largevessel occlusion stroke: a prospective randomised controlled stu	4
Factors associated with infarct volume growth after mechanical thrombectomy in large core infarction: ANGEL-ASPECT insights	4
Long-term functional outcomes improved with deep brain stimulation in patients with disorders of consciousness	4
Standardising the diagnosis and imaging of intracranial atherosclerotic stenosis in Asia: a call for regional consensus	4
0.23-Tesla MRI to differentiate between ischaemic and haemorrhagic strokes within 24 hours of onset: a combined experimental–clinical study	4
Characteristics of brain structural damage related to cerebral small vessel disease in general population with intracranial artery stenosis	4
Residual inflammatory risk predicts long-term outcomes following stenting for symptomatic intracranial atherosclerotic stenosis	4
Chemical Optimization of Cerebral Embolectomy 2 (CHOICE 2) trial: study protocol	4
Thrombus magnetic susceptibility: implications for distal embolisation risk in endovascular therapy	4
Long-term mortality associated with incidental unruptured intracranial aneurysms in neurologically healthy Japanese adults: the Kashima scan study	4
Risk stratification in symptomatic intracranial atherosclerotic disease with conventional vascular risk factors and cerebral haemodynamics	4
Efficacy and safety of edaravone sublingual tablet for patients with cerebral small vessel disease-related cognitive impairment: study protocol for a multicentre, randomised, double-blind, placebo-con	4
Predictors of malignant swelling in space-occupying cerebellar infarction	4

Anaesthesia modality on endovascular therapy outcomes in patients with large infarcts: a post hoc analysis of the ANGEL-ASPECT trial	4
Determinants of prehospital and in-hospital delay in patients with symptomatic carotid stenosis and their influence on the outcome after elective carotid endarterectomy	4
Response to ‘comments on the article ‘sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections’’	3
Stenting for symptomatic intracranial arterial stenosis with different qualifying arteries: a preplanned pooled individual patient data analysis	3
Magnitude of systolic blood pressure reduction following endovascular treatment and clinical outcomes in acute large artery occlusion stroke	3
Vascular dementia has the highest hospitalisation rate in China: a nationwide hospital information system study	3
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial	3
MALAT1 promotes platelet activity and thrombus formation through PI3k/Akt/GSK-3β signalling pathway	3
Association of APOE genotype with CT markers of cerebral amyloid angiopathy in spontaneous intracerebral haemorrhage	3
Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOto	3
ADVISING score: a reliable grading scale based on injury and response for intracerebral haemorrhage	3
When treating acute ischaemic stroke of LVO type, time window prevails over tissue window	3
Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)	3
Intelligent cholinergic white matter pathways algorithm based on U-net reflects cognitive impairment in patients with silent cerebrovascular disease	3
RIC-specific cytoprotective profile mediated by microglia in a mouse model of acute ischaemic stroke	3
Gut Microbiome and Stroke: a Bidirectional Mendelian Randomisation Study in East Asian and European Populations	3
Smoking status and the efficacy of remote ischaemic conditioning: a secondary analysis of the RICAMIS trial	3
Peripheral blood GATA2 expression impacts RNF213 mutation penetrance and clinical severity in moyamoya dis	3
Antiplatelet therapy versus intravenous thrombolysis for mild acute ischaemic stroke: a living systematic review and meta-analysis	3
Endovascular treatment for MILD ischaemic stroke with acute anterior circulation large vessel occlusion: a multicentre, prospective, randomised, clinical trial (MILD-MT) protocol	3